Additionally, flavones may provide benefits to patients independent of their effect on DUX4-induced toxicity, as a recent publication demonstrated that closely-related isoflavone compounds can correct the “hypotrophic” phenotype of FSHD myotubes [93]. Here, DUX4 is linked to facioscapulohumeral muscular dystrophy.